In conclusion, FGFR4 is involved in the proliferation of HCC cells by ERK/CUL3/cyclin E signaling pathway and these findings may provide a potential theoretical basis for treatment by targeting FGFR4 in HCC (Fig 5). The gene discussed is CCNE1; the disease is hepatocellular carcinoma.